A Thirteen-Gene Expression Signature Predicts Survival of Patients with Pancreatic Cancer and Identifies New Genes of Interest
Main Authors: | Newhook, Timothy E., Blais, Edik M., Lindberg, James M., Adair, Sara J., Xin, Wenjun, Lee, Jae K., Papin, Jason A., Parsons, J. Thomas, Bauer, Todd W. |
---|---|
Format: | Online |
Language: | English |
Published: |
Public Library of Science
2014
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4152146/ |
Similar Items
-
Clinical, Molecular and Genetic Validation of a Murine Orthotopic Xenograft Model of Pancreatic Adenocarcinoma Using Fresh Human Specimens
by: Walters, Dustin M., et al.
Published: (2013) -
Co-Treatment with Panitumumab and Trastuzumab Augments Response to the MEK Inhibitor Trametinib in a Patient-Derived Xenograft Model of Pancreatic Cancer1
by: Lindberg, James M., et al.
Published: (2014) -
Thirteen Sudden Deaths from Suffocation
by: Mackenzie, S. Coull
Published: (1890) -
Prognostic Fifteen-Gene Signature for Early Stage Pancreatic Ductal Adenocarcinoma
by: Chen, Dung-Tsa, et al.
Published: (2015) -
Budget deficits and inflation in thirteen Asian developing countries
by: Habibullah, Muzafar Shah, et al.
Published: (2011)